You are in: eMedicine Specialties > Urology > Common Problems of the Urethra Urethral ProlapseArticle Last Updated: Jun 15, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Raymond Rackley, MD, Professor of Surgery, Cleveland Clinic Lerner College of Medicine at CWRU; Co-Section Head, Section of Voiding Dysfunction and Female Urology, Glickman Urological Institute, Cleveland Clinic Foundation Raymond Rackley is a member of the following medical societies: American Urological Association Coauthor(s): Sandip P Vasavada, MD, Co-Head, Section of Female Urology, Joint Appointment, Urological Institute and Department of Gynecology, Co-Director, Center for Pelvic Neuromodulation, Cleveland Clinic Foundation Editors: Allen Donald Seftel, MD, Department of Urology, Associate Professor, Case Western Reserve University; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Mark Jeffrey Noble, MD, Consulting Staff, Urologic Institute, Cleveland Clinic Foundation; J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center; Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio Author and Editor Disclosure Synonyms and related keywords: urethral protrusion through the meatus, vaginal bleeding, protrusion of the distal urethra, urethral protrusion, eversion of the terminal urethra, urethral eversion, everted urethra, strangulated urethral prolapse, intra-abdominal pressure, intraabdominal pressure, distal female urethra, hematuria, prepubertal urethral prolapse, postmenopausal urethral prolapse, urethral mass, urethral caruncle, prolapsed urethra INTRODUCTIONUrethral prolapse is a circular protrusion of the distal urethra through the external meatus. It is a rarely diagnosed condition that occurs most commonly in prepubertal black females and postmenopausal white women. Even less common is strangulated urethral prolapse. Vaginal bleeding is the most common presenting symptom. Upon examination, round doughnut-shaped mucosa is observed protruding from the urethral opening. Because the condition is so rare, the rate of misdiagnosis is high. The differential diagnosis of a urethral mass is broad, ranging from a simple urethral caruncle to rhabdomyosarcoma. Increased physician awareness and early recognition of urethral prolapse avoids unnecessary examinations and patient anxiety. Management of urethral prolapse ranges from medical therapy that consists of topical estrogen use to conservative surgical excision in whom medical therapies fail. History of the ProcedureSolingen first described urethral prolapse in 1732. It is a benign extrusion of the terminal urethra that is associated with vaginal bleeding. Most authors believe urethral prolapse is restricted to the terminal urethra. Various treatments have been used for this type of lesion. In the past, treatment was primarily surgical. Currently, conservative therapy with topical agents is the preferred initial therapy for uncomplicated urethral prolapse. Failure of medical therapy for strangulated urethral prolapse warrants surgical intervention. Many different surgical procedures, ranging from simple manual reduction to complete surgical excision, have been described. Surgical excision has a high cure rate and is the most definitive therapy. Procedures such as cautery, cryotherapy, and ligation of the prolapsed urethra over a Foley catheter are no longer routinely practiced. ProblemUrethral prolapse is defined as the complete eversion of the terminal urethra from the external meatus (see Image 1). Although infrequently reported in the literature, it is a common disorder among postmenopausal women and prepubertal girls. Urethral prolapse must be distinguished from urethral caruncle, in which one quarter of the urethral mucosa protrudes. FrequencyUrethral prolapse is relatively uncommon and has a bimodal age distribution. It occurs almost exclusively in black girls younger than 10 years, with an average age at presentation of 4 years. Although most children with urethral prolapse are black, one report indicated that 61% of affected children are white. In adults, urethral prolapse most commonly occurs in white women after menopause. Approximately 86% of the postmenopausal women with urethral prolapse are white. English literature reports 270 cases involving children and 46 cases involving adults. One report of urethral prolapse in identical twins suggests that heredity may play a role. Strangulated urethral prolapse is more common in adults than in children. EtiologyThe exact cause of urethral prolapse remains unknown; however, several theories have been proposed. These theories may be divided into congenital or acquired defects.
Risk factors for urethral prolapse in children include increased intra-abdominal pressure as a result of chronic coughing or constipation. The relationship between genital trauma and urethral prolapse remains controversial. In elderly people, poor nutrition and hygiene have been reported as additional possible risk factors. Loss of estrogen at menopause has also been cited as a risk factor. Urethral prolapse in elderly women has become much less common since the introduction of estrogen replacement therapy. PathophysiologyUrethral prolapse primarily involves the distal female urethra. The urethra is composed of inner longitudinal and outer circular-oblique smooth muscle layers. Usually, a natural cleavage plane is present between the inner and outer muscle layers. In a healthy female urethra, this cleavage plane firmly adheres to the opposing muscle layers. A prolapsed urethra may result from these 2 muscle layers separating after a sudden episodic increase in intra-abdominal pressure. Disruption of these muscle layers results in complete and circular eversion of the urethral mucosa through the external meatus and leads to urethral prolapse. Swelling and congestion of the prolapsed mucosa create a purse-string effect around the distal urethra, impeding venous return and exacerbating vascular congestion. If left untreated, urethral prolapse may progress to strangulation and eventual necrosis of the protruding tissues. The fundamental anatomical defect of urethral prolapse is the separation of the longitudinal and circular-oblique smooth muscle layers. Surgical apposition of these smooth muscle layers is curative. ClinicalThe two types of urethral prolapse include prepubertal and postmenopausal. Clinical presentation is different for both groups. Patients with prepubertal urethral prolapse are predominantly asymptomatic. Often, urethral prolapse is an incidental finding during routine examination. The most common presentation is vaginal bleeding associated with a periurethral mass. Symptomatic children present with bloody spotting on their underwear or diapers. Hematuria is uncommon. Until urethral prolapse is definitively diagnosed, the presence of blood in the genital area should raise the suspicion of sexual abuse. Voiding disturbances are typically rare in the pediatric population, but when they are present, patients may report dysuria, urinary frequency, or introital pain. Again, hematuria is uncommon. Children may report genital pain if the prolapsed mucosa becomes very large or if thrombosis and gangrene have developed. Furthermore, although reportedly a nonobstructive lesion, acute urinary retention secondary to urethral prolapse has been reported in a young girl. In contrast, patients with postmenopausal urethral prolapse are often symptomatic. Vaginal bleeding associated with voiding symptoms is fairly common. Affected women may report dysuria, urinary frequency or urgency, and nocturia. Either microscopic or gross hematuria may be present. If the prolapsed urethra is large, the mucosal mass may become strangulated, which results in venous obstruction, thrombosis, and necrosis of the prolapsed tissue. Patients with strangulated urethral prolapse present with suprapubic pain, dysuria, hematuria, and urethral bleeding. Attendant urinary tract infection is also common. Upon physical examination, urethral prolapse appears as a doughnut-shaped mass protruding from the anterior vaginal wall. In children, a pinkish orange congested mass may be observed at the center of the urethral meatus. The mass may be painful and tender to palpation. The mucosa is ulcerated in most cases and usually bleeds upon contact. In adults, urethral prolapse appears as erythematous inflamed mucosa protruding from the urethral meatus. The congested mucosa may appear bright red or dark and cyanotic. Depending on the evolution of the process, the prolapsed tissue may appear infected, ulcerated, or necrotic. Urethral prolapse is diagnosed by verifying that a central opening is present within the prolapsed tissue and that this opening is the urethral meatus. In children, observation during voiding or catheterization of the central opening is diagnostic. In adults, urethral catheterization or cystourethroscopy helps verify the presence of the urethral meatus. The absence of a urethral meatus at the center of the prolapsed mucosa precludes the diagnosis of urethral prolapse. The initial diagnosis of urethral prolapse made by the referring pediatrician or emergency department physician is often erroneous because of the rarity of this condition. When evaluating a urethral mass, the differential diagnosis should include urethral or vaginal malignancy, urethral caruncle, ectopic ureterocele, condyloma, and rhabdomyosarcoma. Routine evaluation with intravenous pyelograms and voiding cystourethrograms is unnecessary except in patients who may have evidence of malignancy, prolapsed ectopic ureterocele, or abnormalities in the ureterovesical junction. Urethral masses that were actually sarcoma botryoides or endodermal sinus tumors have been misdiagnosed as urethral prolapse. Urethral leiomyomas and malakoplakia have also been misdiagnosed as urethral prolapse. If the diagnosis is not completely certain after a detailed history and careful physical examination, the patient should be examined under general anesthesia to rule out more serious lesions. Surgical excision and pathologic examination confirm the diagnosis. Although urethral prolapse does not have pathognomonic features, histological examination reveals ulcerated polypoid tissue composed of fibrovascular stroma with dilated veins and a few organized thrombi. Mucosal edema, vascular thrombosis, and inflammatory cells may also be present. Strangulated urethral prolapse appears to be more common in the adult population than in the pediatric population. Patients with strangulated urethral prolapse may report suprapubic tenderness and severe pain during urination. Urethral prolapse is often associated with urinary tract infection. The diagnosis of strangulated urethral prolapse is predicated upon the discovery of an extremely painful, cyanotic, circular mass surrounding the external meatus, and this condition requires emergency surgical excision. For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education article Prolapsed Bladder. INDICATIONSSurgical excision is justified in young patients with symptoms of urethral prolapse or with recurrent urethral prolapse. Optimal treatment for postmenopausal women presenting with symptoms of urethral prolapse or strangulated urethral prolapse ranges from long-term topical vaginal estrogen therapy to simple excision followed by a short period of urethral catheterization. Long-term treatment following simple surgical excision would then consist of topical vaginal estrogen cream. RELEVANT ANATOMYThe adult female urethra is 4 cm long and extends from the bladder neck to the external meatus. The mucosa of the female urethra is lined by transitional cell epithelium that gradually changes to nonkeratinizing squamous epithelium from the bladder neck to the external urethral meatus. Small periurethral secretory glands line the wall of the urethra to provide lubrication to the urethral mucosa. These periurethral glands converge at the distal urethra as Skene glands and empty through 2 small ducts on either side of the external meatus. The submucosa of the female urethra is composed of a rich vascular network of spongy tissue. It nourishes the urethral epithelium and the underlying mucous glands. Both the mucosa and the submucosa are responsible for providing a part of the female continence mechanism, the mucosal seal. The mucosal epithelium and the submucosal vascular plexus are highly responsive to estrogen. Loss of estrogen at menopause may result in atrophy and loss of the mucosal seal, causing intrinsic sphincter dysfunction. Intrinsic sphincter deficiency is a complex form of stress urinary incontinence. The female urethra contains 2 layers of smooth muscle—the inner longitudinal layer and the outer circular-oblique layer. The inner longitudinal smooth muscle layer is thicker and continues from the bladder neck to the external meatus. The outer circular-oblique smooth muscle layer encases the longitudinal fibers throughout the length of the urethra. Usually, these 2 layers adhere to each other by means of strong connective tissue. Weakening or separation of these 2 layers leads to complete urethral prolapse. The female bladder neck functions as an internal sphincter, but it possesses little adrenergic innervation and has limited sphincteric action. The striated urethral sphincter is composed of slow- (type I) and fast-twitch (type II) muscle fibers that form a complete ring around the proximal urethra. The striated urethral sphincter receives dual somatic innervation from the pudendal and pelvic somatic nerves to provide a normal resting urethral closure pressure. Little sympathetic innervation is found in the female urethra, but parasympathetic cholinergic fibers are found throughout the smooth muscle fibers. Activation of the parasympathetic fibers causes the inner longitudinal smooth muscle of the urethra to contract synchronously with the detrusor. Contraction of the longitudinal fibers shortens and widens the urethra to allow normal urination. CONTRAINDICATIONSThose in whom topical estrogen vaginal cream use is contraindicated may include women who have survived breast cancer. Consulting with the patient's oncologist and urologist is necessary. Those in whom surgery is contraindicated include women and children with minimal symptoms who are experiencing urethral prolapse for the first time and those who cannot tolerate a local, regional, or general anesthesia. WORKUPImaging Studies
Diagnostic Procedures
Histologic FindingsUrethral prolapse does not have pathognomonic features; however, histological examination reveals ulcerated polypoid tissue composed of fibrovascular stroma with dilated veins and a few organized thrombi. Mucosal edema, vascular thrombosis, and inflammatory cells may also be present. TREATMENTMedical therapyMedical therapy for urethral prolapse includes local hygiene with sitz baths and topical antibiotic, steroid, or estrogen creams. The effectiveness of medical therapy is debated in the literature. Some authors report that local application of an antibacterial ointment allows symptoms of the prolapsed mucosa to resolve. In one series, the prolapsed urethra persisted at a 3-year follow-up, even though the symptoms disappeared (Redman, 1982). In another series, treatment of urethral prolapse with topical estrogen cream resulted in complete involution in 3-6 weeks, without recurrence (Wright, 1987). Current recommended medical therapy for prepubertal girls includes treatment with sitz baths and topical antibiotics and estrogen cream. The usual regimen consists of the application of estrogen cream to the prolapsed urethra 2-3 times daily for 2 weeks, in combination with sitz baths. The use of antibiotics is optional, depending on the patient's clinical presentation. For women with mild forms of urethral prolapse, the recommended therapy consists of oral conjugated estrogen or topical estrogen cream applied to the prolapsed urethra 2-3 times daily for 2 weeks, in combination with sitz baths. Prescribe antibiotics if infection is present. Failure of medical therapy or the presence of strangulated urethral prolapse mandates surgical excision. Conservative therapy is not recommended when significant thrombosis, necrosis, or bleeding of the prolapsed urethra is present. Surgical therapyIf medical therapy does not rapidly reduce the prolapse, surgery is the treatment of choice. In one reported series, a comparison of treatment modalities (nonoperative vs excision) indicated that patients undergoing early local excision of the prolapse had the lowest complication rates and the earliest convalescence (Jerkins, 1984). Procedures to treat this condition include the following:
The procedures described by Emmet and Keefe are difficult to perform in the small vagina of a child. Simple manual reduction and urethral catheterization for 1-2 days have been effective in minor cases of urethral prolapse; however, recurrence rates are high. Tying a ligature around the prolapsed mucosa over an indwelling urethral catheter causes the tissue to slough in a few days. Some of these procedures have significant morbidity, resulting in urethral strictures and meatal stenosis. They are also associated with partial recurrences, infection, and prolonged recovery. These procedures are not commonly performed today. Some authors feel that a prolapsed urethra is the result of inadequate attachment of the urethra to the pubis. As such, the herniated urethra should be reduced and the bladder and urethra attached to the posterior surface of the pubis and rectus abdominis muscles. However, the Hepburn procedure (ie, suprapubic vesicourethropexy) is too extensive of an operation for this simple lesion and is no longer recommended. The preferred method of removing the prolapsed urethra is excision of the everted mucosa with suturing of the incision and short-term catheterization. Several modifications of this procedure are discussed below. Of these procedures, complete circumferential excision and closure of the incision appears to be the most effective treatment and is associated with minimal complications. Preoperative detailsEradicate any coexisting urinary tract infection with appropriate antibiotics. Discuss the potential benefits and risks when obtaining informed consent from the patient or parents. Complications unique to surgical excision include urethral stenosis, urinary incontinence, and recurrence of prolapse. Intraoperative detailsUsually the operation can be performed in an outpatient setting. Administer general anesthetic. Place the patient in a dorsolithotomy position, and sterilely prepare and drape the vaginal area. Place a Foley catheter. Excise the prolapsed urethra in one of the following ways:
All of these operations serve 2 functions. They remove the nonviable tissue and restore the 2 muscle layers of the urethra to their normal state of apposition. Postoperative detailsAfter surgery, leave the urethral catheter in place for 48-72 hours to allow continuous bladder drainage (see Image 3). Diverting the urine via a Foley catheter prevents irritation and stinging of the urethral mucosa during voiding. Catheterization is unnecessary in children. Discharge the patient home on oral antibiotics and supplemental narcotics. Follow-upThe patient needs to return in 2-3 days for catheter removal. Schedule a follow-up visit for 4-5 weeks later to evaluate the patient's voiding status and to examine the incision site. Following surgical excision of urethral prolapse in postmenopausal women, long-term topical estrogen therapy is recommended. COMPLICATIONSPostoperative complications are unusual, but the following have been reported:
Although ureteral injury is possible during surgical correction of a severely prolapsed urethra, it has not been reported. OUTCOME AND PROGNOSISUse of topical estrogen therapy in postmenopausal women usually suffices as a primary intervention, provided that the therapy is used long-term. For acute interventions that may be warranted based on bleeding and pain, excising the prolapsed mucosa and oversewing of the edges provides the most definitive therapy with the fewest recurrences. Oversewing the mucosal edge restores the coaptation of the longitudinal and circular-oblique muscle layers to prevent any future recurrence. FUTURE AND CONTROVERSIESOptimal management of urethral prolapse consists of initials trials of medical therapy, followed by minimally invasive procedures for refractory conditions. Reported advantages of conservative therapy versus surgery and vice-versa are generally based on personal preference rather than objective randomized prospective studies. Offering medical therapy, at least initially, to children and adults with minimal symptoms is prudent. Medical therapy is also appropriate for patients with a high risk of complications with general anesthesia. Careful follow-up is important. All other patients, including those in whom medical therapy has failed, are good candidates for surgical excision of the prolapsed urethra. Complete excision with oversewing of the mucosa appears to have the highest success rate with the lowest prevalence of recurrences. MULTIMEDIA
REFERENCES
Article Last Updated: Jun 15, 2006 | |||||||||||||||||||||